Clene Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Clene Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $6.42M, a 166.21% increase year-over-year.
- Clene Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $4.42M, a 65.28% increase year-over-year.
- Clene Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $3.27M, a 60.41% increase year-over-year.
- Clene Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $2.41M.
- Clene Inc. stock issued during period, value, new issues for fiscal 2025 was $10.51M, a 43.78% increase from fiscal 2024.
- Clene Inc. stock issued during period, value, new issues for fiscal 2024 was $7.31M, a 83.96% decline from fiscal 2023.
- Clene Inc. stock issued during period, value, new issues for fiscal 2023 was $45.57M, a 297.68% increase from fiscal 2022.
- Clene Inc. stock issued during period, value, new issues for fiscal 2022 was $11.46M, a 23.89% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $6.42M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.42M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $10.51M 10-K · filed 2026-03-17 | |
| 2025-09-30 | $3.27M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.41M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $2.67M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $7.31M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $2.04M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $45.57M 10-K · filed 2025-03-24 | |
| 2023-06-30 | $40.92M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $4.66M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $11.46M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $128.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $9.25M 10-K · filed 2023-03-13 | |
| 2021-06-30 | $9.25M 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |